Bayer Can Start to Look Beyond Litigation

Dow Jones
07/02

0645 GMT - Bayer's progress toward resolving U.S. litigation over its Roundup glyphosate-based weedkiller means investors' focus should start to shift to the fundamental aspects of the business, Deutsche Bank's Virginie Boucher-Ferte says in a research note. "Last week's Supreme Court ruling is pivotal to Bayer's multipronged approach to draw a line under its glyphosate liability," the analyst says. "All in all, we believe it should effectively cap the glyphosate exposure within existing provisions." The German group has a compelling growth profile in both its agricultural and pharmaceutical units, she adds. Deutsche Bank raises its recommendation on Bayer stock to buy from hold, lifting its target price to 60 euros from 45 euros. Shares closed at 49 euros, before news that Bayer plans to separate its Roundup business. (adria.calatayud@wsj.com)

 

(END) Dow Jones Newswires

July 02, 2026 02:45 ET (06:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10